Science & Pipeline
| Pipeline | Indication | Commercial Rights | Pre-clinical | Phase I | Phase II | Phase III | NDA/ Regulatory Approval |
Marketed |
|---|
| 锋脉*/ ARCATUS® (ARVN001) |
Uveitis (Uveitic Macular Edema) | Greater China, South Korea, India, ASEAN countries, Australia, New Zealand |
||||||
| Diabetic Macular Edema |
| MPL® | Myopia and Hyperopia | Global |
| ARVN901 | Corneal Endothelial Dysfunction | Greater China, South Korea |
| ARVN005 | Geographic Atrophy | Globa |
| ARVN601 | Glaucoma | Global |
| IOL Series | Cataract | Global |
| ITEAR® (ARVN701) |
Dry Eye Disease | Greater China, South Korea, ASEAN countries |
| ARVN602 & 603 | Inherited Retinal Degeneration | Global |
| ARVN8 Series | Ophthalmic Healthcare Product Matrix | Global |
| Defocus Lens | Pediatric Myopia Control | Global |
CLOSE